Home » Posts tagged 'rem'

Tag Archives: rem

Cadence Minerals (KDNC) – The former Rare Earth Minerals (REM) changes its name

Further to the announcement of 20 March 2017, the Directors are pleased to confirm that the former Rare Earth Minerals (REM) has changed its name to Cadence Minerals Plc and will be using the AIM symbol KDNC henceforth.

In addition, Cadence has engaged Vox Markets, the agnostic IR platform. By engaging with Vox Markets, Cadence can ensure that both shareholders and the wider professional investment community are fully informed at all times. Investors can download the Vox Markets app www.voxmarkets.co.uk/app and follow ‘KDNC’ at www.voxmarkets.co.uk/company/KDNC to receive push notifications when Cadence feature in the press, release an RNS or feature on a podcast interview.

Cadence’s website can be found at www.cadenceminerals.com, which also contains the Company’ latest presentation that was made at the Master Investor show on the 25 March 2017.

– Ends –

For further information please contact

Cadence Minerals plc

+44 (0) 207 440 0647

Andrew Suckling

Kiran Morzaria

WH Ireland Limited (NOMAD & Broker)

+44 (0) 207 220 1666

James Joyce

James Bavister

Square1 Consulting

+44 (0) 207 929 5599

David Bick

Brian Alexander

About Cadence Minerals:

Cadence is dedicated to smart investments for a greener world. The planet needs rechargeable batteries on a global scale – upcoming supersized passenger vehicles, lorries and buses – require lithium and other technology minerals to power their cells. Cadence is helping find these minerals in new places and extracting them in new ways, which will meet the demand of this burgeoning market. With over £35 million vested in key assets globally, Cadence is helping us reach tomorrow, today.

Cadence invests across the globe, principally in lithium mining projects. Its primary strategy is taking significant economic stakes in upstream exploration and development assets within strategic metals. We identify assets that have strategic cost advantages that are not replicable, with the aim of achieving lower quartile production costs. The combination of this approach and seeking value opportunities allows us to identify projects capable of achieving high rates of return.

The Cadence board has a blend of mining, commodity investing, fund management and deal structuring knowledge and experience, that is supported by access to key marketing, political and industry contacts. These resources are leveraged not only in our investment decisions but also in continuing support of our investments, whether it be increasing market awareness of an asset, or advising on product mix or path to production. Cadence Mineral’s goal is to assist management to rapidly develop the project up the value curve and deliver excellent returns on its investments.

Daily Actions – UK Main & AIM markets 06042016

IntellisysLogoDaily Actions is a daily summary analysis of changes in short term actions from our Daily Recs – AIM and Daily Recs Main markets reports. This report is typically distributed before the open of trading in London

AIM Market

ST Rec. changed
From To
Basic Resources    
Ariana Resources Buy Neutral
Firestone Diamonds Neutral Buy
Landore Resources Neutral Buy
Rare Earth Minerals Neutral Buy
Financial Services    
ADVFN Strong Buy Buy
Manx Financial Buy Neutral
Mirland Development Corporation Neutral Buy
Health Care    
Cyprotex Buy Neutral
Futura Medical Strong Buy Buy
Immunodiagnostic Systems Neutral Buy
Industrial Good & Services    
Cohort Sell Neutral
Falkland Islands Holdings Buy Neutral
Impellam Group Neutral Sell
Servision Neutral Buy
Tanfield Group Neutral Buy
Tangent Communications Sell Neutral
Oil & Gas – Explorers    
Serica Energy Buy Neutral
Oil & Gas – Producers    
Infrastrata Buy Neutral
Pantheon Resources Buy Neutral
Retail    
Stanley Gibbons Group Buy Neutral
Technology    
Brady Neutral Sell
Pennant International Group Buy Neutral
Zoo Digital Group Buy Neutral

Main Market

ST Rec. changed
From To
Aerospace & Defence
Cobham Buy Neutral
Banks    
Barclays Neutral Buy
House Construction    
Persimmon Neutral Sell
Food Producers & Processors    
Cranswick Neutral Sell
Leisure & Hotels    
Restaurant Group Buy Neutral
Media & Entertainment    
UBM Neutral Sell
Oil & Gas    
John Wood Group Buy Neutral

RISK WARNING

Intellisys Intelligent Analysis Limited (‘Intellisys’) does not make personal recommendations. The information in this publication is provided solely to enable you to make your own investment decisions. If you are unsure about dealing in shares and other equity investments, you must contact your financial adviser as these types of investments may not be suitable for everyone. The value of stocks and shares, and the income from them, can fall as well as rise and you may not get back the full amount you originally invested. If denominated in a foreign currency, fluctuations in the exchange rate will also affect the value of stocks and shares and the income from them. Past performance is not necessarily a guide to future performance. You agree to abide fully with Intellisys’ Term & Conditions, which are available to www.intellisys.uk.com

 

The full reports are available from Intellisys Intelligent Analysis website (www.intellisys.uk.com) by clicking on the ‘Research’ tab.

 

 

DISCLAIMER: Intellisys Intelligent Analysis Limited has prepared this report. Intellisys (“Intellisys”) is the trading name of Intellisys Intelligent Analysis Limited. Intellisys Intelligent Analysis Limited is a provider of financial research reports that indicate the possible value of quoted company shares. The information contained within any and all of Intellisys’ reports are designed to present an objective assessment of the possible value or relative value of a company and/or an actuarial sector or stock market index. Intellisys utilises as extensive as possible range of valuation tools and proprietary systems to derive its outputs. The base data for the models are derived from sources believed to be accurate but Intellisys Intelligent Analysis Limited does not warrant or guarantee the accuracy or reliability of the source data or its models and proprietary systems. Subscribers, and casual readers, should not rely upon the Intellisys’ research outputs when forming specific investment decisions but should seek advice specific to their situation and investment requirements from a person authorised under the Financial Services and Markets Act 2000, before entering into any investment agreement.

Intellisys Intelligent Analysis Limited has used reasonable care and skill in compiling the content of this report. No representation or warranty, expressed or implied, is given by any person as to the accuracy or completeness or accuracy of the information and no responsibility or liability is accepted to the accuracy or sufficiency of any of the information, for any errors, omissions or misstatements, negligent or otherwise. In no event will Intellisys Intelligent Analysis Limited, Intellisys or any of its officers, employees or agents be liable to any other party for any direct, indirect, special or other consequential damages arising from the use of this report.

The Intellisys Intelligent Analysis Limited and/or Intellisys reports are not directed to any person in any jurisdiction where (by reason of that person’s nationality, residence or otherwise) the publication or availability of the Intellisys Intelligent Analysis Limited and/or Intellisys information may be prohibited. Persons in respect of whom such prohibitions apply must not access the Intellisys Intelligent Analysis Limited and/or Intellisys reports. Neither this document, nor any copy in whatever form of media, may be taken or transmitted into the United States, Canada, Australia, Ireland, South Africa or Japan or into any jurisdiction where it would be unlawful to do so. Any failure to comply with this restriction may constitute a violation of relevant local securities laws. Recipients of Intellisys Intelligent Analysis Limited and/or Intellisys reports outside the UK are not covered by the rules and regulations made for the protection of investors in the UK.

Any user distributing information taken from any Intellisys Intelligent Analysis Limited or Intellisys report and/or the Intellisys website, in whatever form, to any other person, agrees to attach a copy of this Disclaimer and the Terms and Conditions of Use pages and obtain the agreement of such other person to comply with the terms set forth.

Intellisys’ published reports are published for information purposes and only available to market counterparties, high net-worth and sophisticated individual investors.

No Intellisys report constitutes an offer or invitation to trade, sell, purchase or acquire any shares or other financial instruments in any company or any interest therein, nor shall it form the basis of any contract entered into for the sale of shares or any other financial instrument in any company.

Intellisys Intelligent Analysis Limited believes that the information within each and any of its reports to be correct, but its accuracy or completeness cannot be guaranteed. No representation or warranty, expressed or implied, is given by any person as to the accuracy or completeness of the information and no responsibility or liability is accepted for the accuracy or sufficiency of any of the information, for any errors, omissions or mis-statements, negligent or otherwise.

Intellisys Intelligent Analysis Limited (including its Directors, employees and representatives) or a connected person may have positions in or options or other financial instruments on any of the securities mentioned within a report, and may buy, sell or offer to purchase or sell such securities from time to time, subject to restrictions imposed by internal rules.

Subscribers, and casual reader, are reminded that the value of any financial instrument may go up or down and that past performance is not necessarily a guide to future performance.

Intellisys Intelligent Analysis Limited is not registered with or regulated by any financial regulatory authority and does not offer, provide or purport to provide or offer investment advice. Intellisys Intelligent Analysis Limited can be contacted at Woodfield Cottage, The Street, Mortimer, Berkshire, United Kingdom RG7 3DW.

 

Intellisys Fusion Report – Friday 8th January 2016

IntellisysLogoDaily Actions is a daily summary analysis of changes in short term actions from our Daily Recs – AIM and Daily Recs Main markets reports. This report is typically distributed before the open of trading in London.

AIM Market

ST Rec. changed
Basic Resources From To
Condor Gold Neutral Buy
Atalaya Mining Neutral Buy
Kemin Resources Neutral Buy
Mariana Resources Neutral Buy
Asa Resource Group Buy Neutral
Rare Earth Minerals Neutral Buy
Construction From To
React Energy Neutral Buy
Financial Services From To
Advanced Oncotherapy Neutral Buy
Zoltav Resources Neutral Buy
EKF Diagnostics Holdings Neutral Buy
Public Services Properties Investments Buy Neutral
Ortac Resources Neutral Buy
Health Care From To
Abcam Neutral Sell
Nanoco Group Neutral Buy
Summit Corporation Neutral Buy
ValiRx Neutral Buy
Industrial Good & Services From To
Hydro International Neutral Sell
Impellam Group Neutral Sell
Surface Transforms Neutral Buy
Tangent Communications Sell Neutral
Media From To
Mirada Buy Neutral
Totally Neutral Buy
Oil & Gas – Producers From To
Hydrodec Group Strong Buy Buy
Pantheon Resources Neutral Buy
Retail From To
Stanley Gibbons Group Neutral Buy
Technology From To
Cyan Holdings Buy Neutral
Forbidden Technologies Neutral Buy
Travel & Leisure From To
GVC Holdings Sell Neutral
Minoan Group Neutral Buy
Utilities From To
Greenko Group Sell Neutral

 

Main Market

ST Rec. changed
Building Materials & Fittings From To
Wolseley Neutral Buy
Engineering & Machinery From To
Castings Neutral Sell
Vesuvius Buy Neutral
Rotork Buy Neutral
Food Producers & Processors From To
Cranswick Neutral Sell
General Retail From To
Burberry Group Buy Neutral
JD Sports Fashion Neutral Sell
SuperGroup Buy Neutral
Leisure & Hotels From To
Millennium & Copthorn Hotels Neutral Buy
Media & Entertainment From To
Pearson Neutral Buy
Oil & Gas From To
Hunting Neutral Buy
Personal Care & Household Products From To
PZ Cussons Buy Neutral
Pharmaceuticals & Biotechnology From To
Dechra Pharmaceuticals Neutral Sell
Oxford Biomedica Neutral Buy
Software & Computer Services From To
ComputaCenter Neutral Sell
Speciality & Other Finance From To
Rathbone Brothers Neutral Sell
Support Services From To
Dignity Neutral Sell
RPC Group Neutral Sell
Telecommunication Services From To
Inmarsat Neutral Sell
Utilities From To
Severn Trent Neutral Sell

 

RISK WARNING

Intellisys Intelligent Analysis Limited (‘Intellisys’) does not make personal recommendations. The information in this publication is provided solely to enable you to make your own investment decisions. If you are unsure about dealing in shares and other equity investments, you must contact your financial adviser as these types of investments may not be suitable for everyone. The value of stocks and shares, and the income from them, can fall as well as rise and you may not get back the full amount you originally invested. If denominated in a foreign currency, fluctuations in the exchange rate will also affect the value of stocks and shares and the income from them. Past performance is not necessarily a guide to future performance. You agree to abide fully with Intellisys’ Term & Conditions, which are available to www.intellisys.uk.com

 

The full reports are available from Intellisys Intelligent Analysis website (www.intellisys.uk.com) by clicking on the ‘Research’ tab.

 

 

DISCLAIMER: Intellisys Intelligent Analysis Limited has prepared this report. Intellisys (“Intellisys”) is the trading name of Intellisys Intelligent Analysis Limited. Intellisys Intelligent Analysis Limited is a provider of financial research reports that indicate the possible value of quoted company shares. The information contained within any and all of Intellisys’ reports are designed to present an objective assessment of the possible value or relative value of a company and/or an actuarial sector or stock market index. Intellisys utilises as extensive as possible range of valuation tools and proprietary systems to derive its outputs. The base data for the models are derived from sources believed to be accurate but Intellisys Intelligent Analysis Limited does not warrant or guarantee the accuracy or reliability of the source data or its models and proprietary systems. Subscribers, and casual readers, should not rely upon the Intellisys’ research outputs when forming specific investment decisions but should seek advice specific to their situation and investment requirements from a person authorised under the Financial Services and Markets Act 2000, before entering into any investment agreement.Intellisys Intelligent Analysis Limited has used reasonable care and skill in compiling the content of this report. No representation or warranty, expressed or implied, is given by any person as to the accuracy or completeness or accuracy of the information and no responsibility or liability is accepted to the accuracy or sufficiency of any of the information, for any errors, omissions or misstatements, negligent or otherwise. In no event will Intellisys Intelligent Analysis Limited, Intellisys or any of its officers, employees or agents be liable to any other party for any direct, indirect, special or other consequential damages arising from the use of this report.The Intellisys Intelligent Analysis Limited and/or Intellisys reports are not directed to any person in any jurisdiction where (by reason of that person’s nationality, residence or otherwise) the publication or availability of the Intellisys Intelligent Analysis Limited and/or Intellisys information may be prohibited. Persons in respect of whom such prohibitions apply must not access the Intellisys Intelligent Analysis Limited and/or Intellisys reports. Neither this document, nor any copy in whatever form of media, may be taken or transmitted into the United States, Canada, Australia, Ireland, South Africa or Japan or into any jurisdiction where it would be unlawful to do so. Any failure to comply with this restriction may constitute a violation of relevant local securities laws. Recipients of Intellisys Intelligent Analysis Limited and/or Intellisys reports outside the UK are not covered by the rules and regulations made for the protection of investors in the UK.

Any user distributing information taken from any Intellisys Intelligent Analysis Limited or Intellisys report and/or the Intellisys website, in whatever form, to any other person, agrees to attach a copy of this Disclaimer and the Terms and Conditions of Use pages and obtain the agreement of such other person to comply with the terms set forth.

Intellisys’ published reports are published for information purposes and only available to market counterparties, high net-worth and sophisticated individual investors.

No Intellisys report constitutes an offer or invitation to trade, sell, purchase or acquire any shares or other financial instruments in any company or any interest therein, nor shall it form the basis of any contract entered into for the sale of shares or any other financial instrument in any company.

Intellisys Intelligent Analysis Limited believes that the information within each and any of its reports to be correct, but its accuracy or completeness cannot be guaranteed. No representation or warranty, expressed or implied, is given by any person as to the accuracy or completeness of the information and no responsibility or liability is accepted for the accuracy or sufficiency of any of the information, for any errors, omissions or mis-statements, negligent or otherwise.

Intellisys Intelligent Analysis Limited (including its Directors, employees and representatives) or a connected person may have positions in or options or other financial instruments on any of the securities mentioned within a report, and may buy, sell or offer to purchase or sell such securities from time to time, subject to restrictions imposed by internal rules.

Subscribers, and casual reader, are reminded that the value of any financial instrument may go up or down and that past performance is not necessarily a guide to future performance.

Intellisys Intelligent Analysis Limited is not registered with or regulated by any financial regulatory authority and does not offer, provide or purport to provide or offer investment advice. Intellisys Intelligent Analysis Limited can be contacted at Woodfield Cottage, The Street, Mortimer, Berkshire, United Kingdom RG7 3DW.

 

Quoted Micro 19 October 2015

ISDX

AIM-quoted Rare Earth Minerals (REM) has announced its intention to gain a secondary quotation on ISDX on around 28 October. Executive chairman David Lenigas says that the shares will continue to be traded on AIM. REM has increased its shareholding in ASX-listed European Metals Holdings Ltd, which owns the exploration rights to the Cinovec lithium/tin deposit in the Czech Republic, to 11.07%. REM paid £170,640 for two million shares in European Metals plus two million warrants exercisable at A$0.20 for a 12 month period. Lenigas is also a director of AfriAg (AFRI), an AIM company that has already started trading on ISDX, and Evocutis, which expects to start trading on 19 October. AIM-quoted Sefton Resources says that it investigated the possibility of moving to ISDX if, as appears inevitable, it loses its AIM quotation but says it was not a viable option. This shows that ISDX will not just take any AIM company that wants to move to its market.

Another David Lenigas and Donald Strang vehicle, Leni Gas Cuba Ltd (LGC), has launched a pathfinder prospectus. LGC has already raised £4.525m prior to the flotation. Most of this cash was raised at 2p a share but the majority of shares in issue at the end of July 2015 were issued at 0.01p a share. BVI-registered LGC intends to make investments in Cuban businesses. At this stage there is still a wide range of options in terms of sectors. LGC may also invest 25% of its funds in other Caribbean ventures. LGC has already invested in an oil and gas company and a travel company. The oil and gas investment and related options, which have subsequently been exercised at an additional cost of £100,000, are in the balance sheet at £690,000. The travel investment cost £39,000. If £500,000 of additional cash is raised in the proposed subscription at 5p a share this will provide £148,500 after costs and pro forma cash would be £3.56m. Global Investment Strategy (UK), which is owned by AIM-quoted Octagonal (OCT) where Lenigas and Strang are former directors, currently owns 4.1% of LGC.

Cash shell Chalkstream Investment Company (CHLK) intends to leave ISDX on 14 November. At 0.115p (0.1p/0.13p) a share, the shell is valued at £900,000. There was £621,000 in the bank at the end of May 2015. There was a six month cash outflow of £58,000. The ultimate beneficial owners of Chalkstream are property company director Robert Ware and former Numis media analyst Dominic Buch. Chalkstream joined ISDX on 17 May 2013 when it raised £330,000 at 0.1p a share. There was £754,000 in the bank at that point. Chalkstream was seeking to buy a UK business in the services sector.

Nodding Donkey (NODD) has raised £42,600 at 3p a share and this cash will cover the company’s overheads and help to finance the 86.95% owned subsidiary Equatorial Oil & Gas in its exploration activities in Botswana. The placing is at a significant discount to the market price of 7.75p (7.25p/8.25p) a share, which values the company at £11.5m. The most recent trade was on 1 October at 7.5p a share. At the end of April 2015, Nodding Donkey had £29,000 in the bank and there was a cash outflow of £114,000 in the previous 12 months – according to unaudited accounts. Last month, Equatorial was issued with three petroleum exploration licences in Botswana, which could host shale gas. One licence was issued directly to Equatorial and the other two to Equatorial’s 85%-owned subsidiary Tamboran Botswana. Equatorial has two licences for coal bed methane.

Diversified Gas & Oil (DOIL) has raised a further £1m from the issue of 8.5% unsecured bonds 2020. This will mean that there will be 2.2 million unsecured bonds in issue. The proceeds will be used to develop the company’s oil and gas assets in Ohio and West Virginia

Wey Education (WEYP) founder Zenna Atkins has sold her remaining stake in the educational services provider. The 1.4 million shares were sold on 14 October. The sale removes an overhang and could make the planned move to AIM easier. At 4.5p (4p/5p) a share, Wey is valued at £2m.

AIM

Recruitment services provider Empresaria (EMR) is acquiring Pharmaceutical Strategies for up to $12.1m and this has led to house broker Arden upgrading its 2015 forecasts. The acquisition takes Empresaria into the US healthcare market and boosts the contribution of the sector to the group. The Massachusetts-based recruitment company specialises in pharmacy benefit managers and nurses, which is an area of growing demand in the US. There has been a slight reduction in 2015 estimates for Empresaria but the 2016 pre-tax profit estimate has been raised by 8% to £8.6m, while earnings per share estimates have been increased by 5% to 10.8p.

Infection prevention products supplier Tristel (TSTL) reported better than expected figures for the year to June 2015. All parts of the business improved their revenues, particularly overseas.  Underlying pre-tax profit improved from £1.8m to £2.6m. There was a special dividend of 3p a share and even excluding that the total dividend improved from 1.6p a share to 2.7p a share.  A 2015-16 profit of £2.9m is forecast. Tristel is in the process of getting regulatory approval in the US.

Digital video content distributor Rightster (RSTR) is undertaking a strategic review. The options include a sale of the company, divestures, partnerships or acquisitions – although this will be difficult to finance given the cash outflow from the group. The main problem is the deferred consideration that has been payable in shares and been highly dilutive. There were 137.9 million shares issued in August for past acquisition Base79 and these can be sold from 12 November with the consent of Cenkos. The shares were issued at 15p each compared with the current market price of 10.5p. A further £3.6m worth of shares are due to be issued by the end of 2015. Rightster has already issued a further 6.2 million shares for the deferred consideration of another acquisition.

Staffline (STAF) has acquired Northern Ireland-based recruitment agency Diamond Recruitment for an undisclosed amount. This will enhance the group’s business in Ireland. This deal comes three weeks after the purchase of professional drivers provider Milestone.

MAIN MARKET

Standard list shell Mithril Capital (MITH) has announced plans to acquire Agenda 21 Digital and move to AIM. Mithril has common backers with Satellite Solutions Worldwide (SAT), which was originally shell Cleeve Capital and followed the same route. Trading in Mithril shares was suspended at 3.6p. Mithril joined the standard list on 22 December 2014 and raised £3.32m net at 3p a share and the shares initially started trading at 6.5p each. Mithril subsequently switched its investing strategy from a focus on the resources sector to the technology sector. The purchase of digital media and analytics agency Agenda 21 marks the first step in a strategy to acquire digital focused marketing services and technology businesses. The initial consideration is £3.3m – 65% cash/35% shares – with up to £8.6m in deferred consideration payable based on performance over the next three years. Advertising industry veteran Peter Scott will become chairman of Mithril.

MATCHED BARGAINS

Surface treatments products and services Norman Hay has transferred its quotation from Britdaq to Asset Match. In 2014, revenues grew from £44.8m to £46.5m and underlying profit rose from £2.77m to £3.6m. Net debt was £494,000. Hay’s NAV was £18.9m at the end of 2014, just over one-third of which is intangible assets, whereas the current market cap is £14.8m – at 100p a share. That is equivalent to six times post-tax earnings in 2014.

ANDREW HORE

LATEST EDITION OF AIM JOURNAL AVAILABLE HERE. OCTOBER EDITION INCLUDES REVIEW OF AIM AWARDS WINNERS.

I would like to receive Brand Communications updates and news...
Free Stock Updates & News
I agree to have my personal information transfered to MailChimp ( more information )
Join over 3.000 visitors who are receiving our newsletter and learn how to optimize your blog for search engines, find free traffic, and monetize your website.
We hate spam. Your email address will not be sold or shared with anyone else.